Complement C3 fraction was significantly decreased at baseline in LN Class IV patients, 62.82 ± 11.40 mg/dL (p < 0.001), compared to Class III, 115.97 ± 37.80 mg/dL. This evidence concerns the gene C3 and lobular neoplasia.